2020
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum
Noureddin M, Chan J, Barradas K, Dimick-Santos L, Schabel E, Omokaro S, Anania F, Myers R, Miller V, Sanyal A, Chalasani N, Group L, Anania F, Bajaj J, Barradas K, Berzigotti A, Birman P, Bosch J, Brower A, Calboli D, Chalasani N, Chan J, Charlton W, Dickinson K, Dimick-Santos L, Filozof C, Forsgren M, Fuchs M, Garcia-Tsao G, Gonzalez-Abraldes J, Gruss H, Hansen M, Hosman S, Imperial J, Jones D, Lalazar G, Leinhard O, Lyons E, McColgan B, Mehta R, Mesenbrink P, Miller V, Myers R, Noureddin M, Omokaro S, Pei V, Ratziu V, Regev A, Riccio R, Sanyal A, Schabel E, Seo S, Smith A, Szitanyi P, Traber P. Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum. Gastroenterology 2020, 159: 422-427.e1. PMID: 32353369, DOI: 10.1053/j.gastro.2020.04.039.Commentaries, Editorials and Letters
2005
Ascites
Kbalid S, Garcia-Tsao G. Ascites. Clinical Gastroenterology 2005, 285-299. DOI: 10.1007/978-1-59259-885-4_19.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSevere ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeCause of ascitesAccumulation of fluidHyperstimulation syndromePeritoneal malignancyCompensated cirrhosisPeritoneal tuberculosisPortal hypertensionCommon complicationCardiac failureProspective studyCommon causeDifferential diagnosisPeritoneal cavityAscitesCirrhosisCumulative probabilityPatientsCauseHypertensionComplicationsMalignancySyndromeEtiology